Skip to main content

Dave Muoio

By Dave Muoio | 02:50 pm | March 24, 2021
New data published in JMIR outlines encouraging results from a modified version of the text-based chatbot app.
By Dave Muoio | 04:26 pm | March 23, 2021
Also: Dexcom promotes Jereme Sylvain to EVP and CFO; Amalgam Rx snags CMS' Jennifer Main as COO and CFO.
By Dave Muoio | 01:38 pm | March 23, 2021
Investors have showered the New York company with $876 million to date.
By Dave Muoio | 04:17 pm | March 22, 2021
The telehealth brand's annual revenue increased 80% YoY to $148.8 million in 2020, although its quarterly YoY growth dipped in Q4 compared to the months prior.
By Dave Muoio | 01:32 pm | March 22, 2021
The company said that its platform is tracking more than 325 million patients' healthcare encounters.
By Dave Muoio | 04:07 pm | March 17, 2021
Also: PainChek's app picks up European and Australian regulatory clearances; Digital health access as a social determinant of health.
By Dave Muoio | 12:40 pm | March 17, 2021
The startup's platform now covers more than 20 million lives and is available worldwide.
By Dave Muoio | 04:04 pm | March 16, 2021
The Palo Alto startup said that 2020 was its strongest year to date.
By Dave Muoio | 02:47 pm | March 16, 2021
The Vscan Air comes from a long heritage of handheld imaging devices, keeping some features like a two-sided probe while ditching all the wires.
By Dave Muoio | 10:00 am | March 16, 2021
The new Sleep Sensing feature integrates with Google Fit and is the first health or wellness use of Soli, Google's low-energy radar sensor.